Valproic acid-induced gene expression responses in rat whole embryo culture and comparison across in vitro developmental and non-developmental models

Reproductive Toxicology

Volumn 41, Issue , 2013, Pages 57-66

  Tonk, Elisa C M ^a,b,c   Robinson, Joshua F ^a,b,c   Verhoef, Aart ^a   Theunissen, Peter T ^a,b   Pennings, Jeroen L A ^a,c   Piersma, Aldert H ^a,d  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Netherlands Toxicogenomics Centre   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Embryo; Gene expression; In vitro; Transcriptomics; Valproic acid; Whole embryo culture

Indexed keywords

VALPROIC ACID;

ARTICLE; CHROMOSOME STRUCTURE; CONTROLLED STUDY; DEVELOPMENTAL TOXICITY; EMBRYO; EMBRYO CULTURE; EMBRYONIC STEM CELL; EMBRYOTOXICITY; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION; IN VITRO STUDY; MORPHOGENESIS; NERVE CELL DIFFERENTIATION; NONHUMAN; RAT; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; ZEBRA FISH;

DANIO RERIO; RATTUS;

EMBRYO; GENE EXPRESSION; IN VITRO; TRANSCRIPTOMICS; VALPROIC ACID; WHOLE EMBRYO CULTURE;

ANIMALS; EMBRYO, MAMMALIAN; EMBRYO, NONMAMMALIAN; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, WISTAR; TERATOGENS; VALPROIC ACID; ZEBRAFISH;

EID: 84882656313     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2013.06.069     Document Type: Article

References (41)

1. Robinson J.F., Theunissen P.T., van Dartel D.A., Pennings J.L., Faustman E.M., Piersma A.H. Comparison of MeHg-induced toxicogenomic responses across in vivo and in vitro models used in developmental toxicology. Reproductive Toxicology 2011, 32:180-188.
2. Robinson J.F., Tonk E.C., Verhoef A., Piersma A.H. Triazole induced concentration-related gene signatures in rat whole embryo culture. Reproductive Toxicology 2012, 34:275-283.
3. Chateauvieux S., Morceau F., Dicato M., Diederich M. Molecular and therapeutic potential and toxicity of valproic acid. Journal of Biomedicine & Biotechnology 2010, 2010.
4. Gean P.W., Huang C.C., Hung C.R., Tsai J.J. Valproic acid suppresses the synaptic response mediated by the NMDA receptors in rat amygdalar slices. Brain Research Bulletin 1994, 33:333-336.
5. Mesdjian E., Ciesielski L., Valli M., Bruguerolle B., Jadot G., Bouyard P., et al. Sodium valproate: kinetic profile and effects on GABA levels in various brain areas of the rat. Progress in Neuro-Psychopharmacology & Biological Psychiatry 1982, 6:223-233.
6. VanDongen A.M., VanErp M.G., Voskuyl R.A. Valproate reduces excitability by blockage of sodium and potassium conductance. Epilepsia 1986, 27:177-182.
7. Zeise M.L., Kasparow S., Zieglgansberger W. Valproate suppresses N-methyl-d-aspartate-evoked, transient depolarizations in the rat neocortex in vitro. Brain Research 1991, 544:345-348.
8. Alonso-Aperte E., Ubeda N., Achon M., Perez-Miguelsanz J., Varela-Moreiras G. Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation. Neurology 1999, 52:750-756.
9. Monti B., Polazzi E., Contestabile A. Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Current Molecular Pharmacology 2009, 2:95-109.
10. Clayton-Smith J., Donnai D. Fetal valproate syndrome. Journal of Medical Genetics 1995, 32:724-727.
11. Ubeda-Martin N., Alonso-Aperte E., Achon M., Varela-Moreiras G., Puerta J., Perez de Miguelsanz J. Morphological changes induced by valproate and its administration concomitant with folinic acid or S-adenosylmethionine in pregnant rats. Nutricion hospitalaria: organo oficial de la Sociedad Espanola de Nutricion Parenteral y Enteral 1998, 13:41-49.
12. Tung E.W., Winn L.M. Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects. Molecular Pharmacology 2011, 80:979-987.
13. Robinson J.F., Verhoef A., Pennings J.L., Pronk T.E., Piersma A.H. A comparison of gene expression responses in rat whole embryo culture and in vivo: time-dependent retinoic acid-induced teratogenic response. Toxicological Sciences: An Official Journal of the Society of Toxicology 2012, 126:242-254.
14. Robinson J.F., Verhoef A., Piersma A.H. Transcriptomic analysis of neurulation and early organogenesis in rat embryos: an in vivo and ex vivo comparison. Toxicological Sciences: An Official Journal of the Society of Toxicology 2012, 126:255-266.
15. Theunissen P.T., Robinson J.F., Pennings J.L., de Jong E., Claessen S.M., Kleinjans J.C., et al. Transcriptomic concentration-response evaluation of valproic acid, cyproconazole, and hexaconazole in the neural embryonic stem cell test (ESTn). Toxicological Sciences: An Official Journal of the Society of Toxicology 2012, 125:430-438.
16. van Dartel D.A., Pennings J.L., de la Fonteyne L.J., van Herwijnen M.H., van Delft J.H., van Schooten F.J., et al. Monitoring developmental toxicity in the embryonic stem cell test using differential gene expression of differentiation-related genes. Toxicological Sciences: An Official Journal of the Society of Toxicology 2010, 116:130-139.
17. Piersma A.H., Genschow E., Verhoef A., Spanjersberg M.Q., Brown N.A., Brady M., et al. Validation of the postimplantation rat whole-embryo culture test in the international ECVAM validation study on three in vitro embryotoxicity tests. Alternatives to Laboratory Animals: ATLA 2004, 32:275-307.
18. Luijten M., van Beelen V.A., Verhoef A., Renkens M.F., van Herwijnen M.H., Westerman A., et al. Transcriptomics analysis of retinoic acid embryotoxicity in rat postimplantation whole embryo culture. Reproductive Toxicology 2010, 30:333-340.
19. Robinson J.F., van Beelen V.A., Verhoef A., Renkens M.F., Luijten M., van Herwijnen M.H., et al. Embryotoxicant-specific transcriptomic responses in rat postimplantation whole-embryo culture. Toxicological Sciences: An Official Journal of the Society of Toxicology 2010, 118:675-685.
20. Piersma A.H. Embryotoxicity testing in post-implantation whole embryo culture (WEC) - Method of Piersma DB-ALM Protocol N. 123 1999.
21. Dai M., Wang P., Boyd A.D., Kostov G., Athey B., Jones E.G., et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Research 2005, 33:e175.
22. Benjamini Y., Hochberg Y. Controlling the false discovery rate: A practical and powerfull approach to multiple testing. Journal of the Royal Statistical Society: Series B 1995, 57:289-300.
23. Oliveros J.C. VENNY. An interactive tool for comparing lists with Venn Diagrams 2007.
24. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2009, 4:44-57.
25. Uehara T., Ono A., Maruyama T., Kato I., Yamada H., Ohno Y., et al. The Japanese toxicogenomics project: application of toxicogenomics. Molecular Nutrition & Food Research 2010, 54:218-227.
26. Lamb J., Crawford E.D., Peck D., Modell J.W., Blat I.C., Wrobel M.J., et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006, 313:1929-1935.
27. Binkerd P.E., Rowland J.M., Nau H., Hendrickx A.G. Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats. Fundamental and Applied Toxicology: Official Journal of the Society of Toxicology 1988, 11:485-493.
28. Menegola E., Broccia M.L., Nau H., Prati M., Ricolfi R., Giavini E. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term. Teratogenesis, Carcinogenesis, and Mutagenesis 1996, 16:97-108.
29. Lindhout D., Schmidt D. In-utero exposure to valproate and neural tube defects. Lancet 1986, 1:1392-1393.
30. Costa L.G., Steardo L., Cuomo V. Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects. Pharmacological Reviews 2004, 56:103-147.
31. Vorhees C.V. Behavioral teratogenicity of valproic acid: selective effects on behavior after prenatal exposure to rats. Psychopharmacology 1987, 92:173-179.
32. Moore S.J., Turnpenny P., Quinn A., Glover S., Lloyd D.J., Montgomery T., et al. A clinical study of 57 children with fetal anticonvulsant syndromes. Journal of Medical Genetics 2000, 37:489-497.
33. Hattig H., Helge H., Steinhausen H.C. Infants of epileptic mothers: development scores at 18 months. Advances in epileptology 1987, 579-581. Raven Press, New York, NY. P. Wolf, M. Dam, D. Janz (Eds.).
34. Herrmann K. Effects of the anticonvulsant drug valproic acid and related substances on the early development of the zebrafish (Brachydanio rerio). Toxicology In vitro: An International Journal Published in Association with BIBRA 1993, 7:41-54.
35. Theunissen P.T., Pennings J.L., van Dartel D.A., Robinson J.F., Kleinjans J.C., Piersma A.H. Complementary detection of embryotoxic properties of substances in the neural and cardiac embryonic stem cell tests. Toxicological Sciences: An Official Journal of the Society of Toxicology 2013, 132:118-130.
36. Pennings J.L., Theunissen P.T., Piersma A.H. An optimized gene set for transcriptomics based neurodevelopmental toxicity prediction in the neural embryonic stem cell test. Toxicology 2012, 300:158-167.
37. Pennings J.L., van Dartel D.A., Pronk T.E., Hendriksen P.J., Piersma A.H. Identification by gene coregulation mapping of novel genes involved in embryonic stem cell differentiation. Stem Cells and Development 2011, 20:115-126.
38. Wiltse J. Mode of action: inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin-developmental effects of valproic acid. Critical Reviews in Toxicology 2005, 35:727-738.
39. Eikel D., Lampen A., Nau H. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives. Chemical Research in Toxicology 2006, 19:272-278.
40. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. Journal of Biological Chemistry 2001, 276:36734-36741.
41. Ankley G.T., Bennett R.S., Erickson R.J., Hoff D.J., Hornung M.W., Johnson R.D., et al. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environmental Toxicology and Chemistry/SETAC 2010, 29:730-741.